Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives $22.22 Consensus PT from Analysts
Shares of Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the stock, Marketbeat.com reports. Three analysts have rat…